How can you find QUATS that fit your requirements? - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

How can you find QUATS that fit your requirements?

FeF Chemicals is a Novo Nordisk company that specialises in the supply of ingredients for the pharmaceutical and biopharmaceutical industries, such as and cGMP manufactured Quaternary Ammonium Compounds (usually referred to as Quats) e.g. Benzalkonium Chloride, Cetrimide and Cetrimonium Bromide and Insulin Human for cell culture media.

For our cGMP manufactured Quats we offer:

  • Global regulatory compliance
  • Manufacture in accordance with the highest GMP standards on the market, the ICH Guide Q7 for Active Pharmaceutical Ingredients
  • High purity products
  • Analyses according to multicompendial pharmacopoeias BP, Ph.Eur., USP/NF and JP
  • Regulatory documentation

As an approved supplier by a large number of global leading pharmaceutical companies, FeF Chemicals can assure full traceability and reliability of the raw materials. We have a well-developed management system, allowing tracing where the raw materials are used. We also have close contact with our suppliers and can meet with customer requested specifications. For us, reliability is not just in the system but also in the mindset of our employees.

QUALITY ASSURANCE
Our quality system meets DS/EN ISO 9001 and ICH’s cGMP Guide for Active Pharmaceutical Ingredients (ICH Q7). Uniform quality of finished products is ensured by our efficient quality control systems, computerised materials planning and rigorous laboratory quality control.

CUSTOMIZING QUATS
If the required product is not in the standard assortment, we can design customized products. Our flexible production process can meet customer demands for special chain length distribution and/or solutions of quats mixed in various ratios.

Contact details:
Email: fefinfo@fefchemicals.com
Web: www.fefchemicals.com

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
29%
Oversee medical treatment of patients in the US.
10%
Provide treatment for patients globally.
6%
All of the above.
42%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
FindPharma Custom Search

Click here